0001209191-16-141402.txt : 20160914 0001209191-16-141402.hdr.sgml : 20160914 20160914162048 ACCESSION NUMBER: 0001209191-16-141402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160913 FILED AS OF DATE: 20160914 DATE AS OF CHANGE: 20160914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stejbach Mark CENTRAL INDEX KEY: 0001487937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 161885291 MAIL ADDRESS: STREET 1: C/O TENGION, INC. STREET 2: 2900 POTSHOP LANE, SUITE 100 CITY: EAST NORRITON STATE: PA ZIP: 19403 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-09-13 0 0001419600 Flexion Therapeutics Inc FLXN 0001487937 Stejbach Mark C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 1 0 0 0 Stock Option (right to buy) 15.87 2016-09-13 4 A 0 25000 0.00 A 2026-09-12 Common Stock 25000 25000 D One-third of the shares subject to the option will vest on September 13, 2017 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter. /s/ Jonathan H. Mahlowitz, Attorney-in-Fact 2016-09-14